CV Sciences (CVSI) Receivables (2013 - 2026)
CV Sciences (CVSI) reported Receivables of $391000.0 for Q1 2026, down 9.07% on a YoY basis from $430000.0 in Q1 2025, and down 2.74% sequentially from $402000.0 in Q4 2025.
CV Sciences (CVSI) Receivables (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Receivables data on file, last reported at $391000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 9.07% year-over-year to $391000.0; the trailing twelve-month figure through Mar 2026 stood at $391000.0 (down 9.07% YoY), and the FY2025 full-year result was $402000.0, down 22.99% from the prior year.
- Receivables slipped to $391000.0 in Q1 2026, from $402000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $7.4 million in Q2 2022 to a low of $391000.0 in Q1 2026.
- A 5-year average of $2.5 million and a median of $545000.0 in 2025 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 206.11% in 2022 and plunged 93.99% in 2023, its largest moves.
- Tracing CVSI's Receivables over 5 years: stood at $7.2 million in 2022, then sank by 93.99% to $431000.0 in 2023, then gained by 21.11% to $522000.0 in 2024, then declined by 22.99% to $402000.0 in 2025, then decreased by 2.74% to $391000.0 in 2026.
- Business Quant data shows CVSI's Receivables at $391000.0 in Q1 2026, $402000.0 in Q4 2025, and $405000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 391,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 391,000.00 |
| Dec 31, 2025 | 402,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 430,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 431,000.00 |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 7.17 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 7.35 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 8.16 Mn |
| Jun 30, 2021 | 7.52 Mn |